The Precision Hypertension Care Study
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 280 participants.
Also called NCT02774460
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 280 participants
- Sponsor
- Registry
-
NCT02774460
-
- Other papers using this trial's data
- Heterogeneity in Blood Pressure Response to 4 Antihypertensive Drugs: A Randomized Clinical Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Sweden
- Registry status
- Completed
Technical summary
Registry record NCT02774460. Randomized; quadruple masking; primary purpose treatment. Start 2017-02-20 (actual); primary completion 2021-06-11 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Precision Hypertension Care Study
- Acronym
- PHYSIC
- Condition
- Hypertension
- Intervention (Drug)
- Zestril®
- Intervention (Drug)
- Atacand®
- Intervention (Drug)
- Norvasc®
- Intervention (Drug)
- Hydrochlorthiazide®
- Intervention (Drug)
- Treatment X
- Intervention (Drug)
- Treatment Y
- Intervention (Drug)
- Placebo
- Lead sponsor
- Uppsala University
Record details
- Record id
cardio:ct-nct02774460- Content hash
1aa969fc38cb161d9e88fd22ff74990a5329c18e4e9d4118c69b58fddfbe9348